Bhubaneswar: In a landmark move for healthcare in Odisha and Eastern India, AIIMS Bhubaneswar has launched a comprehensive Liver Transplant Programme and commissioned a state-of-the-art Surgical Robotic System. The facilities were inaugurated virtually by Union Health Minister Jagat Prakash Nadda on Monday.
Aparajita Sarangi, MP, and Union Health Secretary Punya Salila Srivastava were also present.
Nadda called the occasion “momentous and historic,” highlighting that AIIMS Bhubaneswar has rapidly developed into a centre of excellence in tertiary healthcare, medical research, and academic programs.
He said the new facilities will strengthen healthcare infrastructure and provide world-class, life-saving treatments for patients across Odisha and neighbouring states.
The minister congratulated the AIIMS Bhubaneswar team, according to an official statement. He noted that the Institute already performs kidney and bone marrow transplants, and the liver transplant programme marks a major milestone in advancing tertiary healthcare in the region.
Nadda also emphasized the national priority on organ donation. He recalled the PM’s call to make organ donation a mass movement. The liver transplant launch reflects AIIMS Bhubaneswar’s commitment to this vision and is a step forward in promoting organ donation, Nadda said.
The liver transplant facility aims to bring advanced treatment for end-stage liver disease to patients in Odisha and neighbouring states, including West Bengal and Assam. Economically weaker patients can now undergo transplantation and follow-up care without financial hardship, reducing the need for long-distance travel.
The Institute has developed a state-of-the-art Liver Transplant Operation Theatre, a highly advanced ICU, and a dedicated Liver Transplant Specialty Clinic for structured post-transplant care. This ensures seamless treatment, recovery, and long-term monitoring.
As a promising start, two successful liver transplants have already been performed. Both patients are recovering well and leading normal lives, demonstrating the Institute’s growing clinical capabilities.
